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1. Introduction
  Pain is an unpleasant sensation, but it is usually beneficial 
to man and animal. It is mainly a protective mechanism for 
the body, whenever any tissues are being damaged, and it 
causes the individual to react to remove the pain stimulus. 
Typically, it is a direct response to an untoward event 
associated with tissue damage, such as injury, inflammation 
but severe pain can arise independently of any obvious 
predisposing cause (e.g. trigeminal neuralgia), or persistent 
long after the precipitating injury has healed (e.g. phantom 
limb pain). It can also occur as a consequence of brain or 
nerve injury (e.g. following a stroke or herpes infection).
With many pathological conditions, tissue injury is the 
immediate cause of the pain, and this results in the 
local release of a variety of chemical agents, which are 
assumed to act on the nerve terminals, either activating 
them directly or enhancing their sensitivity to other 
forms of stimulation[1,2]. Attention is being focused on the 
investigation of the efficacy of mushroom-based drugs used 
in the traditional medicine because they are cheap and 
have little side effects.
  Mushrooms are the fleshy and edible fruiting bodies 
of several species of fungi, typically produced above 
ground on soil or on its food source[3]. Mushrooms have 
high nutritive and medicinal values, and contribute to 
healthy diet because of their rich source of vitamins, 
minerals and proteins[4]. They comprise a vast and yet 
largely untapped source of powerful new pharmaceutical 
products[5,6]. They are low calorie food with very little fat 
and are highly suitable for obese persons[7]. Pleurotus 
species are commonly known as oyster mushrooms and 
are edible. They are reported to possess several medicinal 
properties. On preliminary phytochemical screening the 
extracts of Pleurotus eous (P. eous) were found to contain 
flavonoid compounds (Mg+HCl reduction test) which are 
known to target prostaglandins involved in the late phase 
of acute inflammation and pain perception. Pleurotus 
mushrooms are the second most important mushrooms in 
production in the world, 25% of total world production of 
cultivated mushrooms. P. eous mushroom belongs to Class 
Agaricomycetes and Family Pleurotaceae. This species has 
been of interest to researchers because its phytochemical 
constituents are similar to those of Pleurotus florida, 
Pleurotus ostreatus and Pleurotus sajor-caju, Pleurotus 
pulmonarious which are commonly used in medicines[4-6,8,9]. 
A bibliographic survey showed that there are no reports 
on the analgesic activity of P. eous in spite of its medicinal 
applications. This prompted us to investigate the effects 
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of pharmacological activities of P. eous mushroom in 
experimental models of analgesia.
2. Materials and methods
2.1. Preparation of the extract
  The fruiting bodies of the mushroom P. eous were obtained 
from Kerala Agricultural University, Trivandrum and 
authenticated by Dr. Lu Lu Das, Professor, Department of 
Plant Biology, College of Agriculture, Vellayani, Kerala 
Agricultural University, Trivandrum. Mushroom fruiting 
bodies were dried at 40-50 曟 for 48 h and powdered. The 
powdered material (250 g) was extracted with petroleum 
ether. The defatted material was extracted with ethyl acetate 
and then with 70% methanol for 8-10 h using Soxhlet 
apparatus. For the preparation of aqueous extract defatted 
material was extracted with hot water (70-80 曟) for 8-10 hrs.
The extract was collected after filtering through Whatmann 
No.1 filter paper. The solvents were completely evaporated 
at 40 曟 using a rotary vacuum evaporator. The residues 
were designated as ethyl acetate (EA) extract and methanol 
extract (MeOH) and aqueous extract (Aqs), respectively. 
2.2. Animals
  Swiss Albino mices were purchased from Animal Breeding 
Centre, Kerala Agricultural University, Trivandrum. They 
were randomly distributed into groups and housed in cages 
(6 per cage) and maintained under standard conditions. All 
animals were fed the standard diet and water ad libitum. 
This project was cleared by Institutional Animal Ethical 
Committee (Approval No: IEAC NO.03/001/10).
2.3. Acute toxicity studies  
  Swiss albino mice of either sex (18-25 g of weight) were 
used for acute oral toxicity study. The study was carried out 
as per the guidelines set by OECD and no adverse effects or 
mortality were detected in the mice up to 4 g/kg p.o., during 
the 24 h observation period. Based on the results obtained 
from this study, the dose for analgesic activity was fixed to 
be 250, 500 and 1 000 mg/kg body weight, for dose dependent 
study. 
2.4. Analgesic activity 
  The animals were divided into 12 groups (n=6). Group I 
served as control received the vehicle only (1% carboxy 
methyl cellulose, 10 mL/kg p.o.). Group II and III served 
as standard, received indomethacin (10 mg/kg b.w.) or 
diclofenac sodium (10 mg/kg b.w.) Groups IV-XII served as 
test received EA, MeOH and Aqs extracts of P. eous at doses 
of 250, 500 and 1 000 mg/kg b.w. p.o., respectively. 
2.4.1. Writhing test 
  The test was carried out according to Koster et al[10]. 
Animals were orally administered with indomethacin 
and diclofenac sodium (10 mg/kg b.w.) as the standard 
drug, P. eous (250, 500 and 1 000 mg/kg b.w.) and vehicle. 
Thirty minutes after treatment, the mice were given an 
intraperitoneal (i.p.) injection of 0.6% v/v acetic acid in a 
volume of 10 mL/kg to induce the characteristic writhing. 
The No. of writhing occurring between 5 and 15 min. after 
acetic acid injection was recorded. The response of the 
extract treated animals was compared with that of control[11]. 
2.4.2. Hot-plate test 
  Mice were placed on an aluminum hot plate kept at (55
依0.5) 曟 for a maximum time of 30 s[12]. Reaction time was 
recorded when the animals licked their fore and hind paws 
and jumped at before (0) and 15, 30, 45 and 60 min after i.p. 
administration of P. eous at doses of 250, 500 and 1 000 mg/kg b.w. 
to different groups. Indomethacin and diclofenac sodium (10 
mg/kg b.w.) is the standard drug. 
2.4.3. Tail clip method 
  A metal artery clip was applied to the root of the mouse’s 
tail to induce pain[13]. A sensitivity test was carried out and 
animals that did not attempt to dislodge the clip within 10 s 
were discarded. The responsive mice were allotted to groups 
of six animals each. The tail clip was applied 60 min after 
oral administration of extract (500 and 1 000 mg/kg b.w.), 
indomethacin and diclofenac (10 mg/kg b.w.). Whereas, 
vehicle treated group was served as control. 
2.4.5. Tail immersion method
  Prior to this experiment the animals were screened for 
the sensitivity test by immersing the tail of mice gently in 
hot water maintained at 55-55.5 曟. The animal dislodging 
the tail from hot water within 5 seconds was selected for the 
study[14]. After oral administration of extracts (500 and 1 000 
mg/kg b.w.), indomethacin and diclofenac (10 mg/kg b.w) 
the reaction time was recorded at 0, 5, 10, 15, 30, 45 and 60 
minutes[15].
2.5. Statistical analysis 
  Results are expressed as Mean依SEM. The difference between 
experimental groups was compared by One-way Analysis of 
Variance (ANOVA) followed by Dunnett’s test. The results were 
considered statistically significant when P<0.05. 
3. Results
  The effects of extract on acetic-acid induced writhes in 
mice have been shown in Table 1. P. eous at dose (250, 
500 and 1 000 mg/kg b.w.) produced a significant (P<0.05) 
decrease in number of writhes in comparison with the control 
group. Diclofenac sodium and indomethacin (10 mg/kg b.w.) also 
showed significant (P<0.05) decrease in number of writhes. 
Table 1  
Effect of EA, MeOH and Aqs extracts of P. eous on acetic-acid 
induced writhes in mice.
Treatment Dose(mg/kg) Number of writhes Inhibition (%)
Control - 36.83依0.60
Diclofenac sodium      10   12.17依0.31* 66.96
Indomethacin      10   14.83依0.31* 59.73
Aqs extract    250  26.33依033* 28.51
Aqs extract    500   23.33依0.21* 36.65
Aqs extract 1 000   20.83依0.31* 43.44
MeOH extract    250   21.17依0.31* 42.52
MeOH extract    500   19.33依0.21* 47.52
MeOH extract 1 000   17.17依0.31* 53.38
EA extract    250   25.67依0.21* 30.30
EA extract    500   22.33依0.21* 39.37
EA extract 1 000   19.83依0.31* 46.16
Each value is the Mean依SEM for 6 mice; *:P<0.05 vs control.
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  Hot-plate test was also assayed to threshold at different 
time of observation (0-60 min) in comparison with control. 
The results presented in Table 2 showed that diclofenac 
sodium and indomethacin (10 mg/kg b.w.) were used as 
standard drug, also that the oral administration of the P. eous 
produced a significant (P<0.05) analgesic effect at doses 250, 
500 and 1 000 mg/kg b.w. in a time-dependent way (P<0.05).
The effect of P. eous on tail clip test is shown as in Table 3. 
The extract caused a significant inhibition of pain at both 
used doses (500 and 1 000 mg/kg b.w.), diclofenac sodium 
(10 mg/kg b.w.), a standard drug, was highly effective 
(P<0.05).
  The effects of extract on tail immersion test in mice have 
been shown in Table 4. Oral administration of P. eous 
produced a significant analgesic effect at both doses of 500 
and 1 000 mg/kg b.w. in a time-dependent way (P<0.05). 
Diclofenac sodium and indomethacin (10 mg/kg b.w.) were 
used as standard drug.
Table 2  
Effect of EA, MeOH and Aqs extracts of P. eous on mice subjected to the hot-plate test.
Treatment Dose(mg/kg)
Reaction time in seconds at time (minutes)
0 min 15 min 30 min 45 min 60 min
Control - 1.50依0.22 2.00依0.26 1.83依0.31   2.17依0.17   2.00依0.00
Diclofenac sodium     10 2.17依0.31 5.83依0.31       12.00依0.63 17.33依0.33 21.83依0.47
Indomethacin     10 1.67依0.21 4.50依0.22 7.33依0.49 12.83依0.47 14.50依0.74
Aqs extract    250 1.83依0.31 3.83依0.31 5.67依0.21   8.00依0.36 10.67依0.33
Aqs extract    500 1.83依0.31 4.33依0.21 7.33依0.33 10.67依0.42 13.33依0.33
Aqs extract 1 000 1.50依0.43 4.00依0.26 6.83依0.47 11.17依0.47 14.67依0.21
MeOH extract    250 1.50依0.22 4.50依0.22 8.00依0.26 10.83依0.31 13.83依0.31
MeOH extract    500 1.83依0.31 4.83依0.31 8.50依0.43 11.50依0.43 14.67依0.42
MeOH extract 1 000 1.83依0.17 4.50依0.22 8.33依0.33 12.33依0.33 16.50依0.43
EA extract    250 1.33依0.33 3.67依0.21 6.17依0.17   8.83依0.31 11.50依0.43
EA extract    500 1.67依0.42 3.83依0.31 6.50依0.22   8.83依0.31 12.17依0.31
EA extract 1 000 2.00依0.26 4.50依0.22 6.83依0.31   9.67依0.21 12.67依0.21
Each value is the Mean依SEM for 6 mice.
Table 3
Effect of EA, MeOH and Aqs extracts of P. eous on tail-clip test in mice. 
Treatment Dose (mg/kg)
Reaction time in seconds at time (minutes)
0 min 5 min 10 min 15 min 30 min 45 min 60 min
Control - 1.67依0.42 2.17依0.17   2.00依0.26   2.17依0.17   2.33依0.21   2.17依0.31   2.00依0.26
Aqs extract*    500 2.17依0.17 3.33依0.21   6.00依0.26   7.50依0.22 10.00依0.26 11.67依0.21 13.33依0.33
Aqs extract* 1 000 2.00依0.26 3.17依0.17   6.50依0.22   9.33依0.21 11.50依0.22 13.50依0.22 14.67依0.21
MeOH extract*    500 2.00依0.26 3.67依0.42   7.50依0.22   9.67依0.21 12.67依0.21 15.00依0.26 16.67依0.42
MeOH extract* 1 000 2.17依0.31 4.83依0.31   8.00依0.36 11.00依0.36 13.50依0.22 15.17依0.31 17.50依0.34
EA extract*    500 2.00依0.42 4.00依0.26   6.33依0.21   9.00依0.36 11.00依0.36 12.67依0.21 14.50依0.22
EA extract* 1 000 1.83依0.42 4.00依0.00   7.17依0.17   9.50依0.22 11.67依0.21 14.00依0.36 16.50依0.22
Diclofenac sodium*      10 2.00依0.26 6.00依0.63 10.17依0.31 12.67依0.33 17.33依0.33 19.67依0.42 24.17依0.31
Each value is the Mean依S.E.M. for 6 mice; *:P<0.05 vs control.
Table 4
Effect of EA, MeOH and Aqs extracts of P. eous on tail-immersion test in mice.
Treatment Dose(mg/kg)
Reaction time in seconds at time (minutes)
0 min 5 min 10 min 15 min 30 min 45 min 60 min
Control - 2.00依0.26 3.17依0.17 2.33依0.21   3.00依0.00   2.83依0.17   2.00依0.26  2.00依0.00
Aqs extract    500 2.67依0.21 4.00依0.26 5.00依0.26   7.00依0.26   9.33依0.33 11.00依0.26 12.33依0.21
Aqs extract 1 000 2.17依0.31 4.00依0.26 6.00依0.26   7.67依0.21 10.17依0.31 12.17依0.31 13.67依0.21
MeOH extract    500 2.00依0.25 3.83依0.17 5.50依0.22   7.67依0.21 10.67依0.21 13.00依0.26 15.33依0.33
MeOH extract 1 000 2.00依0.00 5.00依0.00 6.33依0.21   8.67依0.21 11.83依0.31 14.50依0.22 17.00依0.26
EA extract    500 2.17依0.31 4.17依0.31 6.00依0.36   7.83依0.40   9.33依0.21 11.00依0.26 12.50依0.22
EA extract 1 000 2.50依0.22 4.17依0.17 6.33依0.21   8.17依0.17 10.33依0.21 12.00依0.26 14.00依0.26
Diclofenac sodium      10 2.00依0.36 5.17依0.40 9.17依0.40 15.17依0.47 22.17依0.79 25.67依0.42 27.67依0.42
Indomethacin      10 2.67依0.26 5.17依0.31 9.17依0.31 12.33依0.21 16.00依0.36 20.50依0.43 24.17依0.31
Each value is the Mean依SEM for 6 mice.
4. Discussion
  The data presented here suggests that the P. eous possess 
anti-nociceptive activity. The extract at the doses tested 
was shown to possess anti-nociceptive activity in all the 
nociceptive models, signifying it possess both central and 
peripherally mediated activities. The abdominal constriction 
response induced by acetic acid is a sensitive procedure to 
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evaluate peripherally acting analgesics[16]. In general, acetic 
acid causes pain by liberating endogenous substances such 
as serotonin, histamine, prostaglandins (PGs), bradykinins 
and substance P, which stimulate nerve endings. Local 
peritoneal receptors are postulated to be involved in the 
abdominal constrictions response[17]. The method has 
also been associated with prostanoids in general, that is, 
increased levels of PGE2 and PGF2毩 in peritoneal fluids[18], 
as well as lipoxygenase products[19,20]. The significant 
reduction in acetic acid-induced writhes by P. eous suggests 
that the analgesic effect may be peripherally mediated via 
the inhibition of synthesis and release of PGs and other 
endogenous substances.  The hot-plate, tail-immersion and 
tail-clip tests are useful in elucidating centrally mediated 
antinociceptive responses, which focuses mainly on changes 
above the spinal cord level[21,22]. The significant increase in 
pain threshold produced by P. eous in these models suggests 
involvement of central pain pathways. Pain is centrally 
modulated via a number of complex processes including 
opiate, dopaminergic, descending noradrenergic and 
serotonergic systems[23-25].The analgesic effect produced by 
the extract may be via central mechanisms involving these 
receptor systems or via peripheral mechanisms involved 
in the inhibition of prostaglandins, leucotrienes, and other 
endogenous substances that are key players in inflammation 
and pain[26].
  In conclusion, the present study demonstrates that extracts 
of P. eous has potent analgesic property, which are mediated 
via peripheral and central inhibitory mechanisms. This 
could provide a rationale for the use of this mushroom in 
pain and inflammatory disorders in folk medicine. 
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